Probiotics with protective armor could boost gut health

Probiotics with protective armor could boost gut healthby Cheng Cheng and Zhao Weiwei,Chinese Academy of SciencesSEM images of B. subtilis (A–B), SEM images of ZPS (C–D), SEM images of ZPS-B.s (

Updated on: January 19,2025

Probiotics with protective armor could boost gut health

Probiotics with protective armor could boost gut healthby Cheng Cheng and Zhao Weiwei,Chinese Academy of SciencesSEM images of B. subtilis (A–B), SEM images of ZPS (C–D), SEM images of ZPS-B.s (

Updated on:January 19,2025

Two studies discuss how to get benefits of fiber without side effects

by Marianne Stein,University of Illinois at Urbana-ChampaignDietary fiber promotes digestive health but can also cause side effects. University of Illinois researchers evaluate fiber tolerance i

Updated on: May 29,2024

Two studies discuss how to get benefits of fiber without side effects

by Marianne Stein,University of Illinois at Urbana-ChampaignDietary fiber promotes digestive health but can also cause side effects. University of Illinois researchers evaluate fiber tolerance i

Updated on:May 29,2024

Researchers propose novel model for surgical action triplets recognition

by Li Yuan,Chinese Academy of SciencesCredit: CC0 Public DomainA research group led by Prof. Jia Fucang from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Scienc

Updated on: January 07,2024

Researchers propose novel model for surgical action triplets recognition

by Li Yuan,Chinese Academy of SciencesCredit: CC0 Public DomainA research group led by Prof. Jia Fucang from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Scienc

Updated on:January 07,2024

Certain proteins in breast milk found to be essential for a baby's healthy gut

by FrontiersCredit: CC0 Public DomainMore than 320 million years of mammalian evolution has adapted breast milk to meet all the physiological needs of babies: It contains not only nutrients, but

Updated on: May 28,2024

Certain proteins in breast milk found to be essential for a baby's healthy gut

by FrontiersCredit: CC0 Public DomainMore than 320 million years of mammalian evolution has adapted breast milk to meet all the physiological needs of babies: It contains not only nutrients, but

Updated on:May 28,2024

Two probiotics identified as promising hypertension treatments

Two probiotics identified as promising hypertension treatmentsbyAmerican Society for MicrobiologyCredit: CC0 Public DomainAn estimated 40% of the global adult population have high blood pressure

Updated on: January 24,2024

Two probiotics identified as promising hypertension treatments

Two probiotics identified as promising hypertension treatmentsbyAmerican Society for MicrobiologyCredit: CC0 Public DomainAn estimated 40% of the global adult population have high blood pressure

Updated on:January 24,2024

What Is Bilirubin?

What Is Bilirubin?A Byproduct of Breaking Down Red Blood Cells Involved in DigestionByMark GurarieUpdated on August 23, 2022Medically reviewed byPriyanka Chugh, MDBilirubin is

Updated on: March 26,2024

What Is Bilirubin?

What Is Bilirubin?A Byproduct of Breaking Down Red Blood Cells Involved in DigestionByMark GurarieUpdated on August 23, 2022Medically reviewed byPriyanka Chugh, MDBilirubin is

Updated on:March 26,2024

Signs and Symptoms of Stomach Cancer

Signs and Symptoms of Stomach CancerByJaime R. Herndon, MS, MPHUpdated on June 25, 2023Medically reviewed byOliver Eng, MDThe signs and symptoms ofstomach cancer, also kn

Updated on: March 26,2024

Signs and Symptoms of Stomach Cancer

Signs and Symptoms of Stomach CancerByJaime R. Herndon, MS, MPHUpdated on June 25, 2023Medically reviewed byOliver Eng, MDThe signs and symptoms ofstomach cancer, also kn

Updated on:March 26,2024

Innovative gel offers new hope for treating gastrointestinal leaks

by Stewart Han, Terasaki Institute for Biomedical InnovationGraphical abstract. Credit:Acta Biomaterialia(2023). DOI: 10.1016/j.actbio.2023.10.026In a major advancement in medical technolo

Updated on: January 02,2024

Innovative gel offers new hope for treating gastrointestinal leaks

by Stewart Han, Terasaki Institute for Biomedical InnovationGraphical abstract. Credit:Acta Biomaterialia(2023). DOI: 10.1016/j.actbio.2023.10.026In a major advancement in medical technolo

Updated on:January 02,2024

How a high fat diet allows expulsion of intestinal parasite worms

by Lancaster UniversityHigh fat diet induced obesity protects mice from chronic T. muris infection. Percentage change in basal start weight in wild-type C57BL/6 mice receiving 12 weeks of CD or H

Updated on: June 17,2024

How a high fat diet allows expulsion of intestinal parasite worms

by Lancaster UniversityHigh fat diet induced obesity protects mice from chronic T. muris infection. Percentage change in basal start weight in wild-type C57BL/6 mice receiving 12 weeks of CD or H

Updated on:June 17,2024

Risk factors and diagnostic methods of H. pylori in Saudi Arabia

by Association of Basic Medical Sciences of FBIHThe most common risk factors associated with H.pylori infection in Saudi Arabia. Credit: Biomolecules and BiomedicineDr. Mutasim E. Ibrahim from th

Updated on: March 14,2024

Risk factors and diagnostic methods of H. pylori in Saudi Arabia

by Association of Basic Medical Sciences of FBIHThe most common risk factors associated with H.pylori infection in Saudi Arabia. Credit: Biomolecules and BiomedicineDr. Mutasim E. Ibrahim from th

Updated on:March 14,2024

Microbiota poised for diagnostic and therapeutic roles in clinics within 5–10 years, says expert

Updated on: June 28,2025

Microbiota poised for diagnostic and therapeutic roles in clinics within 5–10 years, says expert

Updated on:June 28,2025

FDA approves Skyrizi for moderately to severely active Crohn disease

Skyrizi (risankizumab-rzaa), an interleukin-23 inhibitor, has received U.S. Food and Drug Administration approval to treat moderately to severely active Crohn disease (CD) in adults, according to AbbV

Updated on: February 19,2024

FDA approves Skyrizi for moderately to severely active Crohn disease

Skyrizi (risankizumab-rzaa), an interleukin-23 inhibitor, has received U.S. Food and Drug Administration approval to treat moderately to severely active Crohn disease (CD) in adults, according to AbbV

Updated on:February 19,2024